Quantcast

Latest Pharmaceutical industry in India Stories

2014-04-23 23:04:16

New research study “Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB) April 23, 2014 Evaluation agreements enable a partner to the deal to gain rights to a technology or compound, subject to a span of time to evaluate the scope, applicability and quality of the technology to its desired endpoint. Typically, the technology is in the initial stage and/or...

2014-04-16 08:31:53

- Bloss to serve on Astellas US Management Committee - NORTHBROOK, Ill., April 16, 2014 /PRNewswire/ -- Astellas US LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced Jeffrey D. Bloss, M.D., has been promoted to the position of Senior Vice President, Medical Affairs Americas, Astellas Scientific and Medical Affairs (ASMA), effective April 1. Bloss will serve as a member of the Astellas US Management Committee. "Jeff has been a key partner and thought...

2014-04-10 12:28:29

LONDON, April 10, 2014 /PRNewswire/ -- Increasing government regulations and requirements, the pharmaceutical patent cliff, industry consolidation, counterfeits and contaminants and expansion into emerging markets are among the many challenges facing the healthcare industry. However, with these challenges come opportunities and not just for the healthcare manufacturer but also for the logistics provider. Ti's latest report, 2014 Global Healthcare Logistics...

2014-04-08 16:22:55

Exec to Support Life Science Research Clients in Booming Southwestern Market SALT LAKE CITY, April 8, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of Kim Killian as Regional Sales Manager of the Southwestern region. "As we've seen remarkable growth opportunities in the western United States, we knew we needed to bring on new and exceptional...

2014-04-07 08:30:43

BOSTON, April 7, 2014 /PRNewswire/ -- Piramal Enterprises' Pharma Solutions Division, a global pharmaceutical contract development and manufacturing organization (CDMO), has received CMO Leadership Awards 2013 in two categories - Quality and Reliability, at a prestigious ceremony at DCAT in New York. Within the Reliability category, Piramal has been recognized as the most "Reliable" CMO among the 5 CMOs shortlisted for this award. (Logo:...

2014-04-04 12:27:58

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/8mt3ng/membrane ) has announced the addition of the "Membrane Technology Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Globally, the membrane technology market is witnessing significant growth due to increasing research and development and production in...

2014-04-03 08:29:12

Financing to Support Entry of OPI's Lead Product Candidate - NHPN-1010 - into Clinical Testing First Half of 2014 OKLAHOMA CITY, April 3, 2014 /PRNewswire/ -- Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc., announced today that it has co-led a $4.1 million Series A private equity financing of Otologic Pharmaceutics, Inc. (OPI), a development-stage biopharmaceutical company committed to developing and commercializing novel...

2014-04-02 04:21:07

LAUSANNE, Switzerland and HAMBURG, Germany, April 2, 2014 /PRNewswire/ -- - Innovative partnership based on Evotec's Target X projects - Evotec and Debiopharm to share discovery and development efforts Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today a research collaboration and licensing deal with Debiopharm Group(TM), Lausanne, Switzerland. The objective of this collaboration is to identify and...

2014-04-01 08:29:32

WOODCLIFF LAKE, N.J., April 1, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been named chief operating officer. In this capacity, Mr. Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in the new product selection process. Mr. Coughlin joins Par from Glenmark Generics, Inc. USA/Glenmark Generics Limited where he most recently served as president...

2014-04-01 08:28:47

DUBLIN, April 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has successfully completed the divestiture of its generics commercial operations in seven markets in Western Europe to Aurobindo Pharma Limited (BSE: 524804). The agreement to divest the commercial operations was announced in January 2014. http://photos.prnewswire.com/prnvar/20130124/NY47381LOGO Aurobindo acquired Actavis' pharmaceutical commercial infrastructure in France, Italy, Spain,...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related